Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (Review)

被引:0
作者
Murata, T
Obiri, NI
Puri, RK
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene therapies, Lab Mol Tumor Biol, Bethesda, MD 20892 USA
[2] Yokohama City Univ, Sch Med, Dept Internal Med 1, Yokohama, Kanagawa 236, Japan
关键词
signal transduction; interleukin-4; interleukin-13; receptors;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have recently demonstrated that two different forms of IL-4R exist; classical or alternative. The classical IL-4R is predominantly expressed in hematopoietic cells and consist of IL-4R beta and IL-2R gamma(c) (gamma(c)) chains. On the other hand, alternative form of IL-4R is predominantly expressed in nonhematopoietic cells and consists of IL-4R beta and IL-13R alpha' chains. Moreover, the alternative form of lL-4R is also utilized as a functional component IL-13R complex. It has been shown that the phosphorylation and activation of JAK3 tyrosine kinase is crucial for IL-4 activation of STAT6 in hematopoietic cells. However, we have recently demonstrated that nonhematopoietic cells lack JAK3 expression. We also demonstrated that in these cells, STAT6 activation is mediated through JAK1 and JAK2 tyrosine kinases instead. Furthermore, our results show that IL-4 and IL-13 signals are transmitted through the alternative form of IL-4R in these cells. Thus, major differences exist between hematopoietic and non-hematopoietic cells with regard to structure and signal transduction through IL-4R and IL-13R systems.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 96 条
[1]   cDNA cloning and characterization of the human interleukin 13 receptor alpha chain [J].
Aman, MJ ;
Tayebi, N ;
Obiri, NI ;
Puri, RK ;
Modi, WS ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29265-29270
[2]  
[Anonymous], CYTOKINES INTERLEUKI
[3]  
BECKMANN MP, 1990, J IMMUNOL, V144, P4212
[4]  
BROWN KD, 1989, J IMMUNOL, V142, P679
[5]   Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain [J].
Caput, D ;
Laurent, P ;
Kaghad, M ;
Lelias, JM ;
Lefort, S ;
Vita, N ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16921-16926
[6]   IL-13 INDUCES PROLIFERATION AND DIFFERENTIATION OF HUMAN B-CELLS ACTIVATED BY THE CD40-LIGAND [J].
COCKS, BG ;
MALEFYT, RD ;
GALIZZI, JP ;
DEVRIES, JE ;
AVERSA, G .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :657-663
[7]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[8]  
Debinski W, 1995, CLIN CANCER RES, V1, P1253
[9]   Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells [J].
Debinski, W ;
Miner, R ;
Leland, P ;
Obiri, NI ;
Puri, RK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22428-22433
[10]   A NOVEL CHIMERIC PROTEIN COMPOSED OF INTERLEUKIN-13 AND PSEUDOMONAS EXOTOXIN IS HIGHLY CYTOTOXIC TO HUMAN CARCINOMA-CELLS EXPRESSING RECEPTORS FOR INTERLEUKIN-13 AND INTERLEUKIN-4 [J].
DEBINSKI, W ;
OBIRI, NI ;
PASTAN, I ;
PURI, RK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16775-16780